Advertisement

Related Videos

Varsha Gandhi, PhD, on Ibrutinib

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

David A. Hyman, MD, JD, on Inclusive Shared Savings

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Advertisement

Advertisement




Apr
17
Today In Oncology
Sequential or Concurrent Radiotherapy and Immunotherapy in Advanced Newly Diagnosed or Refractory NSCLC
Romiplostim for Chemotherapy-Induced Thrombocytopenia
AYA Cancer Survivors and Risk for Earlier Subsequent Primary Neoplasms
Bispecific Antibody Shows Deep Remission in Patients With Relapsed/Refractory Follicular Lymphoma
Is Standard of Care Optimal for the Individual Patient?
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo